Edition:
United Kingdom

Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

124.90SEK
23 Aug 2019
Change (% chg)

-1.05kr (-0.83%)
Prev Close
125.95kr
Open
128.15kr
Day's High
129.20kr
Day's Low
123.85kr
Volume
2,859,764
Avg. Vol
1,393,724
52-wk High
143.00kr
52-wk Low
97.12kr

Latest Key Developments (Source: Significant Developments)

Elekta Q1 EBIT At SEK 236 Mln, Below Expectations
Thursday, 22 Aug 2019 

Aug 22 (Reuters) - Elekta AB (publ) ::INTERIM REPORT, MAY-JULY 2019/20.OUTLOOK 2019/20: NET SALES GROWTH OF 8-10 PERCENT, BASED ON CONSTANT EXCHANGE RATES.OUTLOOK 2019/20: EBITA MARGIN OF AROUND 19 PERCENT.Q1 EBITA INCREASED BY 16 PERCENT TO SEK 448 M (386), CORRESPONDING TO AN EBITA MARGIN OF 13.9 PERCENT (13.7)..Q1 NET SALES SEK 3.23 BILLION VERSUS SEK 3.27 BILLION SEEN IN REFINITIV POLL.Q1 EBIT SEK 236 MILLION VERSUS SEK 274.9 MILLION SEEN IN REFINITIV POLL.Q1 GROSS ORDER INTAKE AMOUNTED TO SEK 4,390 M (3,174), CORRESPONDING TO A 32 PERCENT ORGANIC GROWTH.Q1 GROSS ORDER INTAKE AMOUNTED TO SEK 4,390 M (3,174), CORRESPONDING TO A 32 PERCENT ORGANIC GROWTH..SAYS 13 ELEKTA UNITY ORDERS BOOKED IN QUARTER..  Full Article

Genesiscare To Acquire Nine Elekta Unity Systems For Advanced Cancer Treatment
Tuesday, 30 Jul 2019 

Elekta AB (publ) ::GENESISCARE TO ACQUIRE NINE ELEKTA UNITY SYSTEMS FOR ADVANCED CANCER TREATMENT.GENESISCARE TO ACQUIRE NINE ELEKTA UNITY SYSTEMS FOR ADVANCED CANCER TREATMENT.TOTAL VALUE OF AGREEMENT IS USD 58 MILLION AND WILL BE BOOKED IN Q1 OF ELEKTA'S 2019/20 FISCAL YEAR.AGREEMENT ALSO EXTENDS STRATEGIC PARTNERSHIP BETWEEN GENESISCARE AND ELEKTA.FIRST DELIVERIES ARE SCHEDULED FOR MID-2020..PARTNERSHIP TO INCLUDE A PROGRAM TO ADVANCE ONGOING CLINICAL DEVELOPMENT OF ADAPTIVE THERAPY BASED ON REAL-WORLD EVIDENCE.THIS ORDER BRINGS TOTAL NUMBER OF UNITY SYSTEMS ORDERED BY GENESISCARE TO 10.  Full Article

Elekta And C-RAD Sign Sales And Distribution Agreement
Friday, 12 Jul 2019 

July 12 (Reuters) - Elekta AB (publ) ::CLINICIANS AND CANCER PATIENTS TO BENEFIT FROM ADVANCED IMAGE GUIDED RADIATION THERAPY SOLUTIONS AGREEMENT BETWEEN ELEKTA AND C-RAD.ELEKTA AND C-RAD ANNOUNCED TODAY THAT COMPANIES HAVE SIGNED A SALES AND DISTRIBUTION AGREEMENT.  Full Article

Elekta CEO says expects effects from China purchasing programme this year
Wednesday, 29 May 2019 

May 29 (Reuters) - Elekta AB (publ) CEO in interview with Reuters ::ELEKTA CEO SAYS DON'T YET SEE EFFECT OF CHINA'S MEDICAL EQUIPMENT PURCHASING PROGRAMME, "DEFINITELY" EXPECTS EFFECTS TO COME THIS FISCAL YEAR.  Full Article

Elekta Q4 EBIT SEK 755 Million, Above Estimates
Wednesday, 29 May 2019 

May 29 (Reuters) - Elekta AB (publ) ::Q4 NET SALES SEK 4.1 BILLION .Q4 GROSS ORDER INTAKE SEK 5.40 BILLION VERSUS SEK 4.66 BILLION YEAR AGO.REUTERS POLL: ELEKTA AB Q4 EBIT SEEN AT SEK 653 MILLION; NET SALES AT SEK 3,712 MILLION; GROSS ORDER INTAKE AT SEK 5,092 MILLION.Q4 OPERATING RESULT SEK 755 MILLION.PROPOSES DIVIDEND OF SEK 1.80 PER SHARE FOR FY 2018/2019 (REUTERS POLL: SEK 1.28 PER SHARE).OUTLOOK 2019/20: NET SALES GROWTH OF 8-10 PERCENT.OUTLOOK 2019/20: EBITA-MARGIN OF ABOUT 19 PERCENT.SAYS ALL PRODUCTION AREAS CONTRIBUTED TO GROWTH.SAYS WE EXCEEDED ANNUAL NET SALES TARGET AND DELIVERED ON REVISED EBITA MARGIN TARGET.SAYS DURING FINAL QUARTER WE DELIVERED A GOOD PERFORMANCE.SAYS WE ACHIEVED STRONG NET SALES GROWTH AND CONTINUED A ROBUST ORDER TREND OVERALL.SAYS DURING YEAR DEMAND FOR RADIATION THERAPY SOLUTIONS REMAINED STRONG IN ALL REGIONS..SAYS ALL BUSINESS LINES CONTRIBUTED TO GROWTH, BOTH IN SOLUTIONS AND SERVICES.SAYS LEKSELL GAMMA KNIFE® ALSO HAD.SAYS LEKSELL GAMMA KNIFE® ALSO HAD A VERY STRONG DEVELOPMENT, COMING CLOSE TO STRONGEST YEAR OF ITS HISTORY.SAYS ELEKTA UNITY HAD A GOOD PERFORMANCE WITH HEALTHY ORDER INTAKE AND SALES.SAYS HOWEVER, SOME OF EXPECTED ORDERS FOR Q4 SHIFTED INTO NEW FISCAL YEAR DUE TO LONGER PROCUREMENT PROCESSES WITH UNITY.SAYS OUR EBITA MARGIN IS EXPECTED TO IMPROVE AS WE BENEFIT FROM OUR PROCESS ENHANCING EFFORTS, COGS REDUCTION PROGRAM AND A CONTINUED REVENUE GROWTH FROM OUR INVESTMENTS IN UNITY AND CHINA.  Full Article

BRIEF-Elekta Q4 EBIT SEK 755 Million, Above Estimates
Wednesday, 29 May 2019 

Repeats brief to include alerts relating to Q4 results.:Q4 NET SALES SEK 4.1 BILLION .Q4 GROSS ORDER INTAKE SEK 5.40 BILLION VERSUS SEK 4.66 BILLION YEAR AGO.REUTERS POLL: ELEKTA AB Q4 EBIT SEEN AT SEK 653 MILLION; NET SALES AT SEK 3,712 MILLION; GROSS ORDER INTAKE AT SEK 5,092 MILLION.Q4 OPERATING RESULT SEK 755 MILLION.PROPOSES DIVIDEND OF SEK 1.80 PER SHARE FOR FY 2018/2019 (REUTERS POLL: SEK 1.28 PER SHARE).OUTLOOK 2019/20: NET SALES GROWTH OF 8-10 PERCENT.OUTLOOK 2019/20: EBITA-MARGIN OF ABOUT 19 PERCENT.SAYS ALL PRODUCTION AREAS CONTRIBUTED TO GROWTH.SAYS WE EXCEEDED ANNUAL NET SALES TARGET AND DELIVERED ON REVISED EBITA MARGIN TARGET.SAYS DURING FINAL QUARTER WE DELIVERED A GOOD PERFORMANCE.SAYS WE ACHIEVED STRONG NET SALES GROWTH AND CONTINUED A ROBUST ORDER TREND OVERALL.SAYS DURING YEAR DEMAND FOR RADIATION THERAPY SOLUTIONS REMAINED STRONG IN ALL REGIONS..SAYS ALL BUSINESS LINES CONTRIBUTED TO GROWTH, BOTH IN SOLUTIONS AND SERVICES.SAYS LEKSELL GAMMA KNIFE® ALSO HAD.SAYS LEKSELL GAMMA KNIFE® ALSO HAD A VERY STRONG DEVELOPMENT, COMING CLOSE TO STRONGEST YEAR OF ITS HISTORY.SAYS ELEKTA UNITY HAD A GOOD PERFORMANCE WITH HEALTHY ORDER INTAKE AND SALES.SAYS HOWEVER, SOME OF EXPECTED ORDERS FOR Q4 SHIFTED INTO NEW FISCAL YEAR DUE TO LONGER PROCUREMENT PROCESSES WITH UNITY.SAYS OUR EBITA MARGIN IS EXPECTED TO IMPROVE AS WE BENEFIT FROM OUR PROCESS ENHANCING EFFORTS, COGS REDUCTION PROGRAM AND A CONTINUED REVENUE GROWTH FROM OUR INVESTMENTS IN UNITY AND CHINA.  Full Article

Elekta Says Unity MR-Linac Receives Regulatory Approval For Clinical Use In Japan
Thursday, 23 May 2019 

May 23 (Reuters) - Elekta AB (publ) ::ELEKTA UNITY MR-LINAC RECEIVES REGULATORY APPROVAL FROM JAPANESE MINISTRY OF HEALTH, LABOUR AND WELFARE.ELEKTA AB - ITS ELEKTA UNITY MAGNETIC RESONANCE RADIATION THERAPY SYSTEM HAS BEEN APPROVED FOR CLINICAL USE IN JAPAN.  Full Article

Elekta buys quality assurance systems firm Acumyn
Friday, 27 Jul 2018 

July 27 (Reuters) - Elekta AB (publ) ::ELEKTA DIGITAL STRATEGY STRENGTHENED THROUGH ACQUISITION OF QUALITY ASSURANCE EXPERT ACUMYN.THIS FOLLOWS AN EXCLUSIVE AGREEMENT BETWEEN ELEKTA AND ACUMYN, SIGNED IN 2014, TO COMMERCIALIZE ITS INTEGRATED QUALITY MANAGEMENT SYSTEM, AQUA.AQUA IS A COMPREHENSIVE SOFTWARE PLATFORM THAT COORDINATES AND CENTRALIZES ALL OF THE QUALITY ASSURANCE TESTS THAT NEED TO BE PERFORMED IN A RADIOTHERAPY CLINIC.  Full Article

Elekta Unity receives CE mark
Monday, 18 Jun 2018 

June 18 (Reuters) - Elekta AB (publ) ::ELEKTA UNITY, WORLD'S FIRST HIGH-FIELD MR-LINAC, RECEIVES CE MARK.TODAY ANNOUNCED THAT ITS ELEKTA UNITY MAGNETIC RESONANCE RADIATION THERAPY (MR/RT) SYSTEM HAS RECEIVED CE MARK, CLEARING THE TECHNOLOGY FOR COMMERCIAL SALES AND CLINICAL USE IN EUROPE.  Full Article

Elekta Q4 adjusted EBITA below forecasts, dividend higher
Friday, 1 Jun 2018 

June 1 (Reuters) - Elekta AB (publ) ::Q4 GROSS ORDER INTAKE AMOUNTED TO SEK 4,656 M (4,366).Q4 ADJUSTED EBITA AMOUNTED TO SEK 918 M (779). ITEMS AFFECTING COMPARABILITY WAS SEK 0 M (-253).SAYS EIGHT ELEKTA UNITY ORDERS WERE BOOKED IN QUARTER.SAYS BOARD OF DIRECTORS PROPOSES A DIVIDEND OF SEK 1.40 (1.00) PER SHARE FOR FISCAL YEAR 2017/18.SAYS OUTLOOK FOR 18/19 NET SALES GROWTH OF AROUND 7 PERCENT, BASED ON CONSTANT EXCHANGE RATES.SAYS OUTLOOK FOR 18/19 EBITA MARGIN OF AROUND 20 PERCENT.SAYS RESPONSE IN CHINA REGARDING UNITY HAS BEEN VERY POSITIVE AND WE WILL INSTALL FIRST FIVE SYSTEMS DURING THIS CURRENT FISCAL YEAR.REUTERS POLL: ELEKTA FISCAL Q4 ORDER INTAKE SEEN AT SEK 4,684 MILLION, ADJUSTED EBITA AT SEK 959 MILLION, DIVIDEND AT 1.20 SEK/SHARE.  Full Article

UPDATE 1-Elekta's new orders jump by a third on demand for Unity radiation system

STOCKHOLM, Aug 22 Sweden's Elekta reported on Thursday a 32% rise in the value of new orders in its first quarter thanks to growing demand for its Unity radiation therapy system, although its earnings lagged forecasts.